100
Participants
Start Date
June 28, 2019
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Pembrolizumab Injection
Any checkpoint inhibitor is acceptable
RECRUITING
Bond and Steele Clinic, P.A., Winter Haven
RECRUITING
Compassionate Care Research Group, Inc., Fountain Valley
Lead Sponsor
Collaborators (1)
Pharm-Olam International
INDUSTRY
Persephone Biosciences
INDUSTRY